Efficacy and Safety of Mitomycin-C Augmented Transconjunctival Revision plus Needle Goniopuncture for Failed Deep Sclerectomy
This prospective study demonstrates that transconjunctival needle goniopuncture augmented with mitomycin C is an effective and safe salvage procedure for failed deep sclerectomy, achieving significant and sustained intraocular pressure reduction with an 86.4% success rate at 12 months and a low complication profile.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Glaucoma is a condition where pressure builds up inside the eye, slowly damaging the nerve that carries vision to the brain. To stop this damage, doctors often perform surgery to create a new drainage channel, allowing the fluid inside the eye to escape. One common operation, called deep sclerectomy, involves carefully thinning a layer of the eye's outer wall to let fluid seep out slowly. It is a gentle procedure that avoids the sudden pressure drops of older surgeries, but it has a specific weakness: the body's natural healing response often tries to seal the new opening with scar tissue, or the tiny internal membrane blocking the fluid remains too thick to let enough water pass. When this happens, the surgery fails, and the pressure rises again, leaving the patient in need of further treatment.
A team of researchers at the Ophthalmic Research Center in Iran set out to test a new way to fix these failed surgeries. They focused on a group of twenty-two patients whose eyes had stopped draining properly after the initial deep sclerectomy. Instead of performing a large, invasive operation to start over, the team tried a much smaller, targeted approach. They combined two actions into a single, quick procedure. First, they injected a small amount of a medicine called mitomycin C under the skin of the eye. This drug is known to stop scar tissue from forming. Then, using a very fine needle, they gently poked through the conjunctiva—the clear skin covering the white of the eye—to break up any scar tissue that had formed around the surgery site. Crucially, they also used the needle to carefully pierce the internal membrane that was still blocking the fluid, creating a clear path for the water to flow out.
The results of this approach were immediate and encouraging. Before the procedure, the average pressure inside the patients' eyes was high, sitting at 21.3 millimeters of mercury. Just minutes after the needle work was done, the pressure dropped significantly to an average of 10.3. This was a massive reduction, and the pressure did not bounce back. Over the course of the next year, the pressure remained stable, hovering around 13.6 millimeters of mercury at the twelve-month mark. This level of control was achieved without the need for many eye drops; in fact, the number of medications patients needed fell from an average of more than two before the procedure to less than one a year later.
The study tracked the success of the surgery by looking at how many eyes reached a safe pressure level. After one year, nearly sixty percent of the eyes had achieved a perfect result, with low pressure and no need for medication at all. When including eyes that reached a safe pressure with the help of a few drops, the overall success rate reached eighty-six percent. The procedure was also remarkably safe. In the entire group of twenty-two eyes, there was only one minor complication, where part of the iris got stuck in the new opening, and this was easily fixed with eye drops. The researchers did not see any serious issues like bleeding inside the eye, infection, or dangerously low pressure.
The researchers suggest that this method works well because it tackles the two main reasons why the original surgery failed. By piercing the internal membrane, they removed the blockage that was stopping the fluid from leaving the eye. By injecting the anti-scarring medicine, they prevented the body from sealing the new exit hole with fibrous tissue. This dual approach seems to offer a durable solution for eyes that were previously considered difficult to treat. While the team notes that their study was small and needs to be confirmed by larger trials over a longer period, the findings indicate that this simple, needle-based technique could be a powerful tool for saving vision in patients with glaucoma who have already undergone a failed operation. It offers a way to restore the eye's drainage system without the risks of a major second surgery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.